Bionpharma recalls 500mg Divalproex Sodium Delayed-Release Tablets due to foreign tablets present. Affected lots may cause injury if taken.
Presence of Foreign Tablets/Capsules
Bionpharma is recalling 500mg Divalproex Sodium Delayed-Release Tablets that may contain foreign tablets. This could cause injury if taken by patients needing this medication.
Foreign tablets can be present in the product, which may cause injury if taken by patients. The hazard is not described in detail about how it causes harm.
Patients prescribed Divalproex Sodium Delayed-Release Tablets by a doctor are affected. Those with the specific lot number 704C003 are at highest risk.
Check for the lot number 704C003 on the bottle. The product was made in India and expires December 31, 2028.
Look for the lot number 704C003 on the bottle label.
The recall states foreign tablets may be present, but does not specify if the product is safe to use.
The recall does not provide specific action steps for affected products.
Check the lot number on the bottle; affected products have lot number 704C003.
We’ve drafted a message you can send Bionpharma to request your refund or repair — edit it as you like.
Subject: Recall D-0742-2026 — Bionpharma Bionpharma Hello, I own a Bionpharma that is covered by recall D-0742-2026 from Bionpharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
